GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Current Accrued Expense

Kimia Biosciences (BOM:530313) Current Accrued Expense : ₹0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Current Accrued Expense?

Kimia Biosciences's Current Accrued Expense for the quarter that ended in . 20 was ₹0.00 Mil.


Kimia Biosciences Current Accrued Expense Historical Data

The historical data trend for Kimia Biosciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Current Accrued Expense Chart

Kimia Biosciences Annual Data
Trend
Current Accrued Expense

Kimia Biosciences Semi-Annual Data
Current Accrued Expense

Kimia Biosciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Kimia Biosciences Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines